Market Currents
Oncothyreon (ONTY +2.1%) announces the filing of an Investigational New Drug application with...
-
Tuesday, December 20, 2011, 11:43 AM ETOncothyreon (ONTY +2.1%) announces the filing of an Investigational New Drug application with the FDA for ONT-10, a therapeutic vaccine directed at cancers expressing MUC1. Upon completion of the review, expects to initiate a Phase 1 trials.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
